References
- Mukai K, Shinkai T, Tomonaga K, Shimoto Y. The incidence of secondary tumors of the heart and pericardium: A ten-year study. Jpn J Clin Oncol 1998; 18: 195-201.
- Posner MR, Cohen GI, Skarin AT. Pericardial disease in patients with cancer. The differentiation of malignant from idiopathic and radiation-induced pericarditis. Am J Med 1981; 71: 407-13.
- Fraser RS, Viloria JB, Wang N. Cardiac tamponade as a presentation of extra cardiac malignancy. Cancer 1980; 45: 1697-704.
- Fincher E. Case Report: malignant pericardial effusion as the initial manifestation of malignancy. Am J med Sci 1993; 305: 106-10.
- Muir KW, Rodger JC. Cardiac tamponade as the initial presentation of malignancy: is it as rare as previously supposed? Postcard Med J 1994; 70: 703-7.
- Press OW, Livingston R. Management of malignant pericardial effusion and tamponade. JAMA 1987; 257: 1088-92.
- Chong HH, Plotnick GD. Pericardial effusion and tamponade: evaluation, imaging, modalities, and management. Compr Ther 1995; 21: 378-85.
- King DT, Nieberg RK. The use of cytology to evaluate pericardial effusions. Ann Clin Lab Sci 1979; 9: 18-23.
- Wilding G, Green HL, Longo DL, Urba WJ. Tumors of the heart and pericardium. Cancer Treat Rev 1988; 5: 165-81.
- Vaitkus PT, Herrmann HC, LeWinter MM. Treatment of malignant pericardial effusion. JAMA 1994; 272: 59-64.
- Einama T, Sato K, Tsuda H, Mochizuki H. Successful treatment of malignant pericardial effusion, using weekly paclitaxel, in a patient with breast cancer. Int J Clin Oncol 2006; 11: 412-5.
- Martinoni A. Treatment of neoplastic pericardial effusions. Recenti Prog Med 2006; 97: 206-10.
- Tomkowski WZ, Wisniewska J, Szturmowicz M, Kuca P, Burakowski J, Kober J, et al. Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade. Support Care Cancer 2004; 12: 53-7.